Previous close | 181.50 |
Open | 182.20 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 180.00 - 184.00 |
52-week range | 171.00 - 234.50 |
Volume | |
Avg. volume | 6,263 |
Market cap | 18.015B |
Beta (5Y monthly) | 0.11 |
PE ratio (TTM) | 25.34 |
EPS (TTM) | 7.14 |
Earnings date | N/A |
Forward dividend & yield | 2.75 (1.51%) |
Ex-dividend date | 08 Apr 2022 |
1y target est | N/A |
Today, primary insider Gisle Løhre Johansen, Executive Vice President (EVP), exercised 10,750 stock options at a strike price of NOK 65.95 per share and in separate transactions, purchased and sold the same number of shares. The shares are drawn from Borregaard’s holdings of treasury shares. Please, see attached notifications for persons discharging managerial responsibilities in Borregaard in accordance with Regulation EU 596/2014 (MAR) article 19. After the transactions, Gisle Løhre Johansen o
Borregaard’s operating revenues reached NOK 1,615 million (NOK 1,419 million)2 in the 1st quarter of 2022. EBITDA was NOK 400 million (NOK 302 million). The result increased in all business areas. The net currency impact on EBITDA was positive compared with the 1st quarter of 2021. Higher sales prices and a strong product mix, partly offset by increased energy and freight costs, were the main reasons for the EBITDA improvement in BioSolutions. Higher sales prices more than compensated for lower
26 April 2022: Borregaard ASA (”Borregaard”, OSE ticker: BRG) Presentation of Q1 2022 results Borregaard will report first quarter 2022 results on Tuesday 3 May 2022 at 07:00 CET. A stock exchange announcement will be made. A press release, the quarterly report and a presentation will be made available on https://www.borregaard.com/investors/. A presentation of the first quarter 2022 results will also be held at 08:00 CET at ABG Sundal Collier, Ruseløkkveien 26, Oslo. The presentation can be fol